Dolutegravir-based regimen
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Dolutegravir-based regimen, covering 2020-01-31 to 2023-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients [Phase 2, Phase 3]